ROC Q1 2026 Earnings Surprise Profit Beats Estimates Despite Tepid Market Response OCUL Q1 2026 Earnings EPS Misses Estimates as PreCommercial Biotech Continues Development LCTX Q1 2026 Earnings WiderthanExpected Loss as ClinicalStage Biotech Reports No Revenue TWFG Q1 2026 Earnings Strong EPS Beat Drives Investor Attention Despite Slight Stock Decline PED Q1 2026 Earnings EPS Surges Past Estimates Revenue Details Unavailable Darling Ingredients DAR Q1 2026 Earnings EPS Smashes Estimates by 46 but Guidance Uncertainty Sinks Shares Slightly